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T
he adipocyte-derived hormone lep-
tin is a critical regulator of many
physiological functions, ranging from
satiety to immunity. Surprisingly, very
little is known about the transcriptional
pathways that regulate adipocyte-specific
expression of leptin. In a recent published
study, we pursued a strategy integrating
BAC transgenic reporter mice, in vitro
reporter assays, and chromatin state
mapping to locate an adipocyte-specific
cis-element upstream of the LEP gene in
human fat cells. Quantitative proteomics
(stable isotope labeling by amino acids in
cell culture, SILAC) with affinity enrich-
ment of protein-DNA complexes iden-
tified the transcription factor FOSL2 as a
specific binder to the identified region.
We confirmed that FOSL2 is an import-
ant regulator of LEP gene expression in
vitro and in vivo using cell culture models
and genetic mouse models. In this
commentary, we discuss the transcrip-
tional regulation of LEP gene expression,
our strategy to identify an adipocyte-
specific cis-regulatory element and the
transcription factor(s) responsible for
LEP gene expression. We also discuss
our data on FOSL2 and leptin levels
in physiology and pathophysiology. We
speculate on unanswered questions and
future directions.
Introduction
Leptin is an adipocyte-derived hormone
that regulates food intake and energy
expenditure, acting primarily through the
central nervous system.
1-3 In addition to its
well-established role in metabolism,
leptin also affects physiological processes
as wide-ranging as reproduction, thyroid
function, bone density, and immune
biology.
4,5 Recombinant leptin has been
developed as a drug for treating insulin
resistance in patients with lipodystrophy.
6
Although early studies using leptin as a
weight loss agent in human obesity proved
disappointing,
7 recent trials using leptin in
combination with the pancreatic polypep-
tide amylin show some promise.
8 There
has also been interest in using leptin to
improve insulin action in a weight-loss
independent fashion; however, recom-
binant methionyl human (r-Met hu)
leptin did not enhance insulin sensitivity
in obese subjects with type 2 diabetes.
9
In the two decades since leptin was first
identified, over 20,000 papers have been
written describing leptin’s actions in
physiology and pathophysiology. In stark
contrast to the wealth of data regarding the
functions of leptin, however, our know-
ledge about the mechanisms involved in
the transcriptional regulation of leptin
gene expression, particularly the basis for
its adipocyte-specific expression, is rather
limited. Leptin is regulated primarily at the
transcriptional level, and a wide variety of
physiological conditions and pharmaco-
logical agents have been shown to affect its
expression, including fasting and feeding,
insulin, glucocorticoids, thiazolidinediones
and even leptin itself.
4,10,11 These studies
are summarized in Table 1.
Transcriptional Regulation
of LEP Gene Expression
Leptin (encoded by the LEP gene in
humans, Lep in mice) is generally
expressed in an adipocyte-specific fashion.
Small amounts of leptin have been
reported in brain, pituitary, trophoblast,
stomach, mammary epithelial cells, liver,
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4,12-14 but
the physiological importance of this
low level expression, if any, has not been
determined.
The proximal promoters of the LEP
gene in mouse and human have been
characterized
15,16 and a classic TATA box
has been identified, as well as binding sites
for C/EBP, Sp-1, GR, and CREB, and
an E box element that may bind
SREBP1c.
17-20 Although a transgenic
reporter driven by a 762 bp leptin
proximal promoter cassette was able to
drive gene expression in vivo, it showed
lower levels of expression in adipocytes
than in a variety of non-adipose tissues and
was not affected by fasting, suggesting that
this region is not responsible for adipose
tissue specificity of leptin expression or
physiological regulation of leptin gene
expression.
21 Recently, the transcription
factor activator protein-2β (AP-2 β) has
been shown to inhibit LEP expression by
direct binding to the promoter.
22 Various
SNPs have been reported in the porcine
leptin promoter that correlate with Lep
expression
23,24 and demethylation of
specific CpG islands occurs during
adipogenesis, associated with the onset of
Lep expression
25
All these studies have been limited by
the fact that they have focused on the
proximal promoter and/or on pre-specified
adipocyte transcription factors. In fact,
several major obstacles have impeded
progress in identifying transcriptional
pathways responsible for regulation of
adipocyte-specific leptin gene expression,
including (1) unreliable methods for
unbiased detection of distal cis-regulatory
elements, (2) insufficient tools to identify
an unknown transcription factor binding
to a known cis-regulatory element, and (3)
a lack of good cell culture models for
studying leptin gene expression in vitro. It
is worth noting that the workhorse model
of adipocyte research, the 3T3-L1 cell line,
expresses extremely low levels of Lep
26 and
is thus unsuitable for these studies. Recent
advances in all of these areas encouraged us
to pursue the mechanism of adipocyte-
specific leptin gene expression once again.
27
Identification of a cis-Regulatory
Element for Adipocyte-Specific
LEP Gene Expression
We utilized a multi-step approach to
finding cis-regulatory elements that direct
lep gene expression. First, we sought to
map such regions grossly, using BAC-
transgenic reporter mice that express
EGFP from the Lep translational start site.
Analyzing multiple transgenic founders
carrying BACs with varying lengths of
Lep flanking sequences allowed us to
narrow down the region required for
adipose-specific expression and demon-
strated that the three Lep exons, both
introns, and 5.2 kb of 5' flanking sequence
were sufficient to drive adipocyte-specific
EGFP expression. Next, we performed
fine-mapping in vitro, by “tiling” across
the upstream flanking region and through
both introns with PCR primers, to
generate reporter constructs that we could
test in cultured human adipocytes. These
cells are derived from human adipose
stromal cells (hASCs), which can be
differentiated into mature adipocytes in
vitro and produce high levels of leptin.
This effort identified a single 1 kb region
approximately 4.5 kb upstream of the LEP
transcriptional start site (TSS) that acts as
enhancer in mature adipocytes. Further
deletion and point mutations allowed us to
discover a 30 bp region that was required
for enhancer activity. Interestingly, we had
previously performed chromatin state
mapping in human adipocytes in culture,
part of which involved mapping histone
modifications associated with active and
poised enhancers.
28 The region we iden-
tified by reporter assays overlay an active
enhancer region
29,30 in our chromatin state
maps (the only such place in the vicinity),
which provided significant reassurance
that we had identified a region of bona
fide importance.
Identification of the Transcription
Factor(s) for Adipocyte-Specific
LEP Gene Expression
Once a relevant cis-regulatory element is
found, it can be very difficult to identify
the cognate transcription factor(s) that
bind and activate it. The most common
approach is to use computational motif
finding to find sequences that suggest
a particular factor. We tried this and found
several interesting motifs for the androgen
receptor (AR), peroxisome proliferator-
activated receptor a (PPARa) and
nuclear factor erythroid 2-related factor 1
(NFE2L1). Unfortunately, functional
Table1. Summary of factors regulating leptin gene expression in adipocytes
Physiological conditions References Direction of effect
Fasting 11, 26, 35 ↓
Feeding 11, 26, 35 ↑
Obesity 37 ↑
Adipocyte volume 34 ↑
Pharmacological agents References Direction of effect
Insulin 26, 38, 39 ↑
Glucose 40 ↑
Glucocorticoids 38, 39 ↑
Hexosamines 41–43 ↑
Cytokines (TNF, IL-1 and LIF)
and lipopolysaccharide (LPS)
44, 45 ↓
b3-adrenergic agonist (CL316,243) 35 ↓
Leptin 46 ↓
Thiazolidinediones (TZD) 10 ↑
Transcription factors References Direction of effect
C/EBPa 17–19 ↑
ADD1/SREBP1 20 ↑
AP-2b 22 ↓
FOSL2 27 ↑
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experiments) failed to demonstrate that
any of these predicted factors were impor-
tant in leptin expression. We therefore
used our identified 30 bp cis-regulatory
element as bait in an unbiased mass
spectrometry-based quantitative proteo-
mics approach combining stable isotope
labeling by amino acids in cell culture
(SILAC) with affinity enrichment of
protein-DNA complexes using biotiny-
lated DNA as affinity baits.
31 To add
specificity, we performed the assay in
cultured human adipocytes as well as
murine adipocytes differentiated from
embryonic fibroblasts, both of which
express leptin. Several transcription factors
were found in each model, but FOSL2
and JUND were the only ones to appear in
both. FOSL2 and JUND are both mem-
bers of the AP1-transcription factor family,
which includes FOS, FOSB, FOSL1,
JUN, JUNB and JUND. We demon-
strated that FOSL2 binds to our enhancer
in mature human adipocytes, but not in
pre-adipocytes, using ChIP-PCR.
FOSL2 is an Important Regulator
of LEP Gene Expression In Vitro
and In Vivo
To demonstrate the functional importance
of FOSL2, we knocked it down with
RNAi in human adipocytes; as predicted,
this led to reduced LEP gene expression.
Unfortunately, Fosl2 global knockout mice
die shortly after birth and before most
adipose development is complete, so leptin
levels in these animals cannot be inter-
rogated. We did look at Fosl2 heterozygous
mice, which have normal adiposity how-
ever, and they show reduced circulating
leptin, as do mice with adipocyte-specific
deletion of Fosl2. In addition, osteoblastic
precursor cells taken from the skulls of
global Fosl2 knockout mice can be
differentiated into adipocytes in vitro;
these cells display lower Lep gene expres-
sion. Gain-of-function studies were a bit
harder to perform, in that overexpression
of Fosl2 in mature adipocytes did not
affect leptin expression. However, forced
expression of Fosl2 during the develop-
ment process resulted in adipocytes with
normal overall differentiation but elevated
leptin expression. Similarly, osteoblastic
precursors from Fosl2-transgenic mice
showed higher Lep expression when
differentiated into adipocytes in vitro.
Since the Fosl2-transgenic mice suffered
from systemic fibrosis and inflammation,
32
metabolic studies of these animals could
not be conducted. It appears that Fosl2 is
both necessary and sufficient for leptin
expression in adipocytes, but it must be
present during the differentiation process
to exert its effects. This implies that Fosl2
has both direct and indirect actions on the
Lep gene.
Roles of FOSL2 in Regulating
Leptin Levels in Physiology
and Pathophysiology
As mentioned above, apart from being
expressed in adipocytes, Lep mRNA
synthesis in adipocytes is regulated by a
variety of physiological and experimental
stimuli. In mice, there are depot-specific
differences in Lep mRNA content, with
inguinal fat expressing higher leptin levels
than retroperitoneal or epididymal adipose
tissue.
33 There also appears to be a direct
relationship between adipocyte volume
and Lep expression regardless of depot.
34
In our study, a correlation of increased
levels of LEP gene expression with
increased levels of FOSL2 gene expression
was observed during the course of differen-
tiation of human adipocytes and in
different adipose depots in mice. In
addition, we showed that stimulation of
mature human adipocytes with dexa-
methasone resulted in increased LEP
expression and simultaneous rise in
FOSL2 expression.
Fasting and Feeding Regulation
of Leptin
One of the most important physiological
functions of leptin is the regulation of
fasting-feeding behavior.
1 Fasting reduces
Lep mRNA and feeding increases it.
35 We
measured Fosl2 mRNA during the fed
state and after 24 h of fasting, but we did
not detect any significant differences. It is
very possible that the mechanisms regu-
lating adipocyte-specific gene expression of
Lep are different from the mechanisms
which regulate other physiological func-
tions of Lep, such as fasting and feeding. It
is worth pointing out that our approach
was geared toward the discovery of
regulators of adipocyte-specific expression
during differentiation, so it is perhaps
unsurprising that Fosl2 might be not a
regulator of the fasting-feeding response.
Roles of FOSL2 in Regulating
Leptin Levels in Obesity
To determine if Fosl2 plays a role in the
elevated Lep expression observed in
obesity, we analyzed Fosl2 expression in
different mouse models of obesity. In mice
with diet-induced obesity as well as in
mice with genetic obesity (db/db), we
found that increased Lep gene expression
was accompanied by increased Fosl2 levels.
A gene expression analysis of samples of
subcutaneous fat from a human cohort
with varying BMIs confirmed this asso-
ciation in humans.
Conclusions and
Unanswered Questions
Several issues, however, remain
unresolved. First of all, we do not yet
understand how FOSL2, which is not
tissue restricted to adipocytes, can regulate
adipose-specific gene expression. There are
several intriguing possible mechanisms,
many of which are known to be employed
by members of the AP-1 transcription
factor family, to which FOSL2 belongs.
These include differential expression,
composition and orientation of the hetero-
dimeric binding partners, post-trans-
lational modifications, and interaction
with ancillary proteins.
36 Interestingly,
although we identified JUND as a poten-
tial binding partner on our 30 bp cis-
regulatory element, we could not
demonstrate a specific requirement for
this or any other Jun isoform in Lep
expression. Perhaps there is greater func-
tional redundancy among the Jun proteins
than between FOS, FOSL1 and FOSB,
which apparently cannot compensate for
the loss of FOSl2 in leptin expression.
Other factors may also be acting in concert
with FOSL2. For example, there is a bona
fide PPARc binding site at the 5' end of the
1 kb cis-regulatory region we discovered.
Perhaps PPARc plays a role in enabling
FOSL2 binding during adipogenesis.
170 Adipocyte Volume 1 Issue 3Our results should by no means be
taken to exclude a possible role for other
cis-regulatory regions important for Lep
expression. Our BAC transgenic results
suggest that multiple regions, especially at
the 3' end of the Lep gene, may be
involved as well. For example, truncation
of the 3' flanking sequence in our BAC
transgenic reporter mouse model led to a
significant decrease of EGFP expression in
adipose tissue and increased EGFP expres-
sion in other tissues. Taken together, these
data suggest that many genomic regions
and transcription factors will eventually be
shown to regulate leptin expression.
Our study provided one of the first
clues into the transcriptional regulation of
the medically important adipokine leptin.
Despite the fact that leptin levels are
primarily regulated at the transcriptional
level, our understanding of the factors at
play has been poorly developed. We
utilized an integrated strategy that com-
bined BAC transgenesis, human reporter
assays, epigenomics, and unbiased quanti-
tative proteomics to identify FOSL2. We
believe that a similar multi-pronged
approach will be required to tackle many
of the remaining problems in tissue-
specific transcriptional regulation.
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